Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 54 of 54 entries
View as:
Phase: N/A
Priority: Normal
Start: 03/31/25
End: 12/31/26
Due: 12/31/27
Phase: N/A
Priority: Normal
Start: 09/25/24
End: 04/21/26
Due: 04/21/27
Phase: N/A
Priority: Normal
Start: 08/11/24
End: 06/30/25
Due: 06/30/26
Phase: N/A
Priority: Normal
Start: 10/30/24
End: 06/30/25
Due: 06/30/26
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Efficacy and Safety of HRS-7535 in for Heart Failure With Preserved Ejection Fraction and Obesity | NCT06820099 | Shandong Suncadia Medicine Co., Ltd. | user2@example.com | None | 2025-03-31 | 2026-12-31 | 2027-12-31 | - | - | 2025-07-14 |
| A Study of HRS-7535 Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequately Controlled With Diet and Exercise | NCT06672172 | Shandong Suncadia Medicine Co., Ltd. | user2@example.com | None | 2024-09-25 | 2026-04-21 | 2027-04-21 | - | - | 2025-07-14 |
| A Trial of HRS-1893 in Patients With Obstructive Hypertrophic Cardiomyopathy | NCT06516068 | Shandong Suncadia Medicine Co., Ltd. | user2@example.com | None | 2024-08-11 | 2025-06-30 | 2026-06-30 | - | - | 2025-07-14 |
| A Study of Safety and Tolerability of Multiple Doses of HRS-7535 in Obese Subjects | NCT06621316 | Shandong Suncadia Medicine Co., Ltd. | user2@example.com | None | 2024-10-30 | 2025-06-30 | 2026-06-30 | - | - | 2025-07-14 |